2010

Van Huynh, M.D.
(Will graduate in June 2010)

2009

David Simon, M.D.
Attending Physician – Millers Children’s Hospital

Dr. Simon had the opportunity to focus his research on mutations of the tumor suppressor p53 .  Publication of this research has been submitted.  Also interested in platelet dysfunction, he has published an article entitled “Platelet function defects” in Haemophilia.

2008

Elyssa Rubin, M.D.
Attending Physician – Children’s Hospital of Orange County

Dr. Rubin’s research goal was to understand the underlying mechanisms of tumor progression in Osteosarcoma in order to define targets for novel therapies.  This research was published in Molecular Cancer Therapy.

2007

Loan Bui-Hsieh, M.D.
Attending Physician, Children’s Hospital of Orange Co.

Dr. Hsieh’s primary research project in Factor XIII began with a question in molecular genetics.  Factor XIII has several common polymorphisms often known as single nucleotide polymorphisms (SNPs) that occur in the normal population. Her research studied the effects of these SNPs on clot dynamics as measured by thromboelastrography.

Amit Soni, M.D.
Attending Physician – Children’s Hospital of Orange Co.

Dr. Soni conducted a Phase I clinical, randomized, double-blind, cross-over study to assess safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A patients.  He is a leading member of our Hematology clinical trials and has a special interest in Hemophilia studies.

2005

Amy Lovejoy, M.D.
Director, Hemophilia Treatment Center Rady’s Children’s Hospital

Dr. Lovejoy’s research included a clinical trial of recombinant factor XIII in patients with factor XIII deficiency. She also performed several related projects. She was awarded a Bayer Fellowship Grant. Her research project has been accepted for publication in Blood.

2000

Jorge DiPaola, M.D.
Associate Professor of Pediatrics and Genetics
The Postle Family Chair in Pediatric Cancer and Blood Disorders
University of Colorado, The Children's Hospital

Dr. DiPaola’s research involved determining the effect of platelet glycoprotein polymorphisms on the bleeding manifestations in patients with type 1 von Willebrand disease. This research was published in Blood. He currently is a leading expert on the genetics of von Willebrand disease.

1999

Ivan Kirov, M.D.
Director, Recurrent Cancer Program
Attending physician Children’s Hospital of Orange County

Amal Abu-Ghosh, MBBS
Georgetown University

Francisco Bracho, M.D.
Georgetown University

1997

Robert Sweetman, M.D.
Vice President, Global Affairs, Wyeth Pharmaceutical

Tulika Seth, M.D.
All India Institute of Medical Sciences, Dept. of Pediatrics/Div. of Pediatric Hematology/Oncology New Dehli, India

1995

Joseph Rosenthal, M.D.
Director - Pediatric Bone Marrow Transplant Program
City of Hope Hospital, Duarte, CA

1993

Eileen R. Gillian, M.D.
Assistant Professor of Pediatrics, University of
Connecticut Medical Center, Department of Pediatric Hematology/Oncology

*Due to changes in the pediatric hematology/oncology program at CHOC, there were no fellows in 2001-2002.